N GENE RES LABORATORIES INC has a total of 12 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are ObsEva SA, SUCAMPO PHARMACEUTICALS INC and TAP HOLDINGS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | China | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Hong Kong | 1 | |
#6 | Hungary | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mandl Jozsef | 7 |
#2 | Febbraio Mark Anthony | 5 |
#3 | Szilvassy Zoltan | 3 |
#4 | Tory Kalman | 3 |
#5 | Nagy Peter Literati | 2 |
#6 | Kolonics Attila | 2 |
#7 | Takacs Kalman | 2 |
#8 | Egri Janos | 2 |
#9 | Bernath Sandor | 2 |
#10 | Balogh Gabor | 2 |
Publication | Filing date | Title |
---|---|---|
HU1800298A2 | Combination of beta blocker and hydroximic acid derivative with reduced side effects | |
US2020179363A1 | Methods for treating nash and for preventing nash-induced hcc |